Analystreport

Ra Pharmctl Inc (NASDAQ: RARX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

RA PHARMACEUTICALS  (RARX) 
Last ra pharmaceuticals earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rapharma.com/news-investors